Surgery Partners, Inc. (NASDAQ: SGRY) Reports Results of 2026 Annual Meeting of Stockholders
Brentwood, TN, June 5, 2026 – Surgery Partners, Inc. (“the Company”) (NASDAQ: SGRY) has announced the results of its 2026 Annual Meeting of Stockholders, held on June 5, 2026. The meeting covered several key proposals, including the election of directors, an advisory vote on executive compensation, and the ratification of its independent auditor. These outcomes could have a material impact on governance and future strategic direction, and are essential for shareholders and investors to consider.
Key Highlights of the Meeting
- Record Date and Voting Shares: As of the record date (April 8, 2026), there were 130,798,102 shares of common stock outstanding and eligible to vote.
- Three Key Proposals: Shareholders voted on the election of Class II directors, an advisory vote on executive compensation (the “say-on-pay” vote), and ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal 2026.
Details of the Proposals and Voting Results
1. Election of Class II Directors
The following individuals were re-elected as Class II directors to serve until the Company’s 2029 annual meeting of stockholders:
- Devin O’Reilly
- Brent Turner
- Laura L. Forese, M.D.
| Name | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Devin O’Reilly | 90,059,419 | 23,613,725 | 6,243,195 |
| Brent Turner | 110,147,882 | 3,525,262 | 6,243,195 |
| Laura L. Forese, M.D. | 91,121,777 | 22,551,367 | 6,243,195 |
Shareholder Impact: All director nominees were re-elected by a significant margin, ensuring continuity in board leadership and corporate strategy. No new directors were introduced. This result may reassure investors seeking stability but may disappoint those advocating for board changes or new perspectives.
2. Advisory Vote on Executive Compensation (“Say-on-Pay”)
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|
| 111,639,092 | 2,018,777 | 15,275 | 6,243,195 |
Shareholder Impact: The executive compensation plan received overwhelming support (over 97% approval), indicating strong shareholder confidence in the Company’s leadership and alignment of management incentives with shareholder interests. However, this is a non-binding advisory vote, so while it reflects shareholder sentiment, the company is not legally required to act on it.
3. Ratification of Ernst & Young LLP as Independent Auditor for Fiscal Year 2026
| Votes For | Votes Against | Abstentions |
|---|---|---|
| 117,204,890 | 62,950 | 24,648 |
Shareholder Impact: The re-appointment of Ernst & Young LLP was ratified with nearly unanimous support, providing continuity and stability in the Company’s financial reporting and audit processes.
Other Key Information for Shareholders
- Emerging Growth Company Status: Surgery Partners, Inc. is not considered an Emerging Growth Company under SEC rules.
- Security Information: The Company’s common stock trades on the NASDAQ under the ticker symbol “SGRY”.
- Principal Executive Office: 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027. Main phone: (615) 234-5900.
Potentially Price Sensitive Information
- There were no director changes, no rejected proposals, and no announced changes to executive compensation or auditor. This suggests that the shareholder base is largely satisfied with current management and board direction, which may be viewed positively by the market, but is unlikely to result in significant share price movement in the absence of other news.
- No contentious governance issues or shareholder activism was evident in the voting patterns.
Conclusion
All proposals presented at the Surgery Partners, Inc. 2026 Annual Meeting were approved by wide margins. This signals investor confidence in the Company’s leadership, governance, and strategic direction. No immediate or dramatic shifts in corporate policy or leadership are expected as a result of this meeting.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult with a financial advisor before making investment decisions. The information provided is based on the Surgery Partners, Inc. Form 8-K as filed with the SEC on June 5, 2026.
